Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intravitreal bevacizumab (Avastin) causing acute glaucoma: an unreported complication.

× No keyword cloud information.

19 in total

1. Quality of bevacizumab compounded for intravitreal administration.

Authors: J M Palmer; W M Amoaku; F Kamali
Journal: Eye (Lond) Date: 2013-06-21 Impact factor: 3.775

2. Management of non-arteritic anterior ischemic optic neuropathy.

Authors: Sohan Singh Hayreh
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2009-12 Impact factor: 3.117

3. Serous retinal detachment following combined photodynamic therapy and intravitreal bevacizumab injection.

Authors: Eui Yon Kim; Jong Wan Kim; Jun Bum Kim; Ho Min Lew
Journal: Korean J Ophthalmol Date: 2009-06-09

4. Repeated intravitreal injections of antivascular endothelial growth factors and risk of intraocular pressure medication use.

Authors: Qi N Cui; Iga N Gray; Yinxi Yu; Brian L VanderBeek
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2019-05-31 Impact factor: 3.117

5. Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling.

Authors: Lu Liu; David A Ammar; Lindsey A Ross; Naresh Mandava; Malik Y Kahook; John F Carpenter
Journal: Invest Ophthalmol Vis Sci Date: 2011-02-22 Impact factor: 4.799

Review 6. Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.

Authors: S Priya Narayanan; Esraa Shosha; Chithra D Palani
Journal: Pharmacol Res Date: 2019-06-15 Impact factor: 7.658

7. Treatment of myopic choroidal neovascularization with posterior sub-Tenon's bevacizumab injection (Avastin ®).

Authors: I-Chia Liang; Yu-Ying Chang; Tong-Sheng Lee; Yi-Ru Lin; Kwan-Rong Liu
Journal: Int Ophthalmol Date: 2014-02-02 Impact factor: 2.031

8. Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery.

Authors: Brennan D Eadie; Mahyar Etminan; Bruce C Carleton; David A Maberley; Frederick S Mikelberg
Journal: JAMA Ophthalmol Date: 2017-04-01 Impact factor: 7.389

Review 9. A review of anti-VEGF agents for proliferative diabetic retinopathy.

Authors: P Osaadon; X J Fagan; T Lifshitz; J Levy
Journal: Eye (Lond) Date: 2014-02-14 Impact factor: 3.775

Review 10. Off-label use of bevacizumab for the treatment of age-related macular degeneration: what is the evidence?

Authors: Focke Ziemssen; Salvatore Grisanti; Karl Ulrich Bartz-Schmidt; Martin S Spitzer
Journal: Drugs Aging Date: 2009 Impact factor: 3.923